CME Mission Statement
The mission of the American Association for the Study of Liver Diseases is to advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care.
AASLD sponsors educational activities that increase scientific knowledge and address professional practice gaps by improving competence and performance.
The purpose of the CME Program is to improve knowledge and increase competence of physicians, non-physicians and healthcare providers, by disseminating the latest information about the science and practice of hepatology, liver transplantation and hepatobiliary surgery to a national and international audience of professionals. AASLD will expand its impact on education, research, training, and therapy of liver disease through ongoing educational collaborations with other US and international healthcare organizations and societies. Professional practice gaps are addressed by providing physicians with evidence-based educational activities that can improve the approach to diagnosis or treatment of patients with liver and biliary diseases. AASLD aims to impart knowledge, skills, and resources to facilitate life-long education.
The content of educational activities sponsored by the AASLD addresses the pathophysiology and management of acute and chronic diseases including liver transplantation, as well as advances in research relevant to all areas of hepatology. Topics include viral hepatitis, non-viral hepatitis, fatty liver disease/steatohepatitis, cholestasis, autoimmune disorders, genetic liver diseases, hepatotoxicity, portal hypertension, liver fibrosis, hepatobiliary cancer, pediatric liver disease, liver failure, liver surgery and transplantation. Areas of educational focus are provided by the membership directly or through conference surveys/evaluations, by special interest groups and educational committees tasked to identify basic and clinical research needs, and through the AASLD practice guidelines highlighting gaps in knowledge or advances in the field. In addition, specific programs focus on career development and performance improvement.
The target audience at AASLD-sponsored CME activities encompasses U.S. as well as international physicians and other healthcare professionals specializing in adult and pediatric hepatology, gastroenterology, surgery, pathology, anesthesiology, radiology and related basic sciences, and trainees in each of these disciplines. Participants come from academic and scientific institutions as well as from practice-based medical settings. All healthcare professionals involved with the study, treatment and management of liver disease are invited to participate whether or not they are members of AASLD.
The AASLD provides a wide variety of educational activities to meet the needs of the association’s members and hepatology healthcare professionals. The association sponsors, co-sponsors or collaborates in several activities annually, including but not restricted to:
All educational activities sponsored by AASLD are intended to promote life-long professional development and competence of its constituents. CME activities incorporate the feedback from participants on topics such as presentation format, clinical relevance, improved competence and freedom of commercial bias. AASLD is engaged in Maintenance of Certification, and is developing programs directed toward practice improvement and re-certification. In addition, AASLD provides non-CME educational materials such as online audio/PowerPoint webcaptures and slide sets.
Education is an integral component of AASLD’s Strategic Plan. A strong CME program enables a discussion forum on how new research in the field of hepatology and liver transplantation can be integrated with clinical expertise, and access to state-of-the art and evidence-based content to diagnose, treat, and improve the health of patients.
The expected result of the CME program is to increase learners’ competence and facilitate scientific progress in the fields of hepatology, liver transplantation and hepatobiliary surgery and promote the application of evidence-based care to patients with liver disease to ultimately improve patient outcomes. Success in achieving these results is measured directly by members, non-member participants, and committees, who report the impact of AASLD educational activities on their research and/or clinical practice.
Governing Board, February 2005
Governing Board, August 2008
Governing Board, October 2010
Governing Board, August 2013
Governing Board, August 2014